White House says all states will receive international-reference pricing for some Medicaid drugs
A White House official said all 50 states will receive prices tied to those in other countries for some Medicaid-covered drugs under a federal model.
A White House official said President Donald Trump would announce that every state Medicaid program will receive international-reference pricing for some covered medicines. The federal GENEROUS model lets participating states buy drugs at prices aligned with those in other countries.
The administration said the approach would save state programs billions of dollars, but The Hill reported that the basis for its projected savings and the effect on costs and access were unclear.